Fig. 6From: Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinomaKaplan–Meier survival curves for disease-specific survival (DSS) and progression-free survival (PFS) according to the co-expression levels of SALL4/ALDH1A1 proteins in serous ovarian carcinoma (SOC) patients. A high level of the co-expression of SALL4/ALDH1A1 proteins was found to be significantly associated with shorter DSS (P = 0.034) (A) and PFS (P = 0.018) (B) in patients with SOCBack to article page